Infection and chemotherapy

The Korean Society of Infectious Diseases (대한감염학회)
권호 표지
DOI QR코드

DOI QR Code

Drug-Resistant Extrapulmonary Tuberculosis

폐외결핵 환자에서의 항결핵제 내성

  • Cho, Oh-Hyun (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Ki-Ho (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Seong-Yeon (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Moon, Song-Mi (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chong, Yong-Pil (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Mi-Na (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sang-Oh (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Sang-Ho (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Woo, Jun-Hee (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Yang-Soo (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Sung-Han (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine)
  • 조오현 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 박기호 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 박성연 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 문송미 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 정용필 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 김미나 (울산대학교 의과대학 서울아산병원 진단검사의학과) ;
  • 이상오 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 최상호 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 우준희 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 김양수 (울산대학교 의과대학 서울아산병원 감염내과) ;
  • 김성한 (울산대학교 의과대학 서울아산병원 감염내과)
  • Published : 2011.06.30
⟨ Previous Next ⟩

Abstract

The prevalence and pattern of drug-resistant extrapulmonary tuberculosis (TB) is not well characterized in Korea. Therefore, we assessed the incidence of drug resistance for extrapulmonary TB in adult patients at a tertiary hospital. We retrospectively reviewed the medical records and results of drug susceptibility test in all culture-confirmed extapulmonary TB patients during an 18-month period. Out of a total of 168 cases in which the drug susceptibility test was performed, resistance to at least one anti-TB drug was found in 15 cases (8.9%), and multidrug resistance, in which TB was resistant to at least isoniazid and rifampin, was found in 3 cases (1.8%).

Keywords

References

  1. Korean National Tuberculosis Association. Anti-tuberculous drug resistance surveillance in Korea. Available from: http://www.knta.or.kr/. Accessed 1 February 2011.
  2. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis 2009;49:1350-7. https://doi.org/10.1086/605559
  3. Park WI, Kang BS, Park JS, Nam JY, Kim CS, Kim JU, Kim DY, Kim TM, Yoon SJ, Huh AJ, Yeom JS, Chang KH, Song YG, Kim JM. Clinical manifestations and diagnosis of extrapulmonary tuberculosis. Korean J Infect Dis 2002;34:47-54.
  4. Kim SH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med 2007;167:2255-9. https://doi.org/10.1001/archinte.167.20.2255
  5. Cho OH, Park KH, Kim T, Song EH, Jang EY, Lee EJ, Chong YP, Choi SH, Lee SO, Woo JH, Kim YS, Kim SH. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect 2009;59:56-61. https://doi.org/10.1016/j.jinf.2009.05.006
  6. Lin JN, Lai CH, Chen YH, Lee SS, Tsai SS, Huang CK, Chung HC, Liang SH, Lin HH. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 2009;13:620-5.
  7. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, Cave MD, Bates JH. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004;38:199-205 https://doi.org/10.1086/380644
  8. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006.362. Geneva: WHO; 2006.
  9. Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, Cheung WC, Yuen KY. Risk factors for development of paradoxical response during antituberculosis therapy in HIVnegative patients. Eur J Clin Microbiol Infect Dis 2003;22:597-602. https://doi.org/10.1007/s10096-003-0998-z
  10. Song EJ, Baek DH, Jung JY, Lee SR, Lee MH, Lee SH, Lee JH, Lee KD, Lee BH, Kim SH. Paradoxical response developed during the antituberculous treatment in tuberculous pleurisy. Tuberc Respir Dis 2008;64:427-32. https://doi.org/10.4046/trd.2008.64.6.427
  11. Al-Majed SA. Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 1996;90:211-4. https://doi.org/10.1016/S0954-6111(96)90289-9
  12. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, Lee JK, Kim SJ. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6.
  13. Kim MJ, Kim HR, Hwang SS, Kim YW, Han SK, Shim YS, Yim JJ. Prevalence and its predictors of extrapulmonary involvement in patients with pulmonary tuberculosis. J Korean Med Sci 2009;24:237-41. https://doi.org/10.3346/jkms.2009.24.2.237
  14. Kong JH, Lee SS, Kang HY, Park JS. The prevalence of initial drug resistance among pulmonary tuberculosis patients. Tuberc Respir Dis 2008;64:95-101. https://doi.org/10.4046/trd.2008.64.2.95
  15. Yang H, Field SK, Fisher DA, Cowie RL. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility. Int J Tuberc Lung Dis 2005;9:288-93.

Cited by

  1. A Case of Tuberculous Optochiasmatic Arachnoiditis vol.82, pp.5, 2011, https://doi.org/10.3904/kjm.2012.82.5.642
  2. Clinical Usefulness ofrpoBGene Sequence Analysis in Lymph Node Tuberculosis vol.44, pp.5, 2011, https://doi.org/10.3947/ic.2012.44.5.357
  3. Rifampin-resistant Relapsed Tuberculosis Confirmed by Molecular Technique vol.44, pp.6, 2011, https://doi.org/10.3947/ic.2012.44.6.485
  4. Testicular tuberculosis in multidrug-resistant pulmonary tuberculosis vol.19, pp.4, 2013, https://doi.org/10.1007/s10156-012-0508-2
  5. Diagnosis and treatment of extrapulmonary tuberculosis vol.57, pp.1, 2011, https://doi.org/10.5124/jkma.2014.57.1.34
  6. Diagnosis and Treatment of Extrapulmonary Tuberculosis vol.78, pp.2, 2011, https://doi.org/10.4046/trd.2015.78.2.47
  7. Epidemiological perspective of drug resistant extrapulmonary tuberculosis vol.5, pp.4, 2011, https://doi.org/10.5495/wjcid.v5.i4.77
  8. Clinical Response to Treatment of Central Nervous System Tuberculosis in Non-Human Immunodeficiency Virus-Infected Adolescents and Adults vol.4, pp.4, 2011, https://doi.org/10.4236/jtr.2016.44020